Aims. The
Aims. To analyze outcomes reported in studies of
Aims. The
In 2010, we published results of
Incidence of Congenital talipes equino varus [CTEV] is 1 to 2 per 1000 birth, Out of all cases 20% cases are Non-idiopathic. The management of non-idiopathic CTEV, however, continues to be challenging due to Rigidity, Poor skin condition, Bony changes, Vascularity and Associated congenital abnormalities. In recent literature, short term results of
Clubfoot deformity is the most common congenital musculoskeletal disorder (1). Approximately one in one thousand people are born with at least one clubfoot; between 150,000 and 200,000 babies are born with a clubfoot each year (2). Eighty percent of these cases occur in developing countries, and the majority is left untreated. When infants are treated with a non-invasive casting technique pioneered by Ignacio
Introduction: The
Introduction and Aims: The
Congenital Talipes Equinovarus (CTEV) occurs in approximately 1 in 1000 live births. Most cases occur as an isolated birth defect and are considered idiopathic. The widespread adoption of the
Congenital talipes equinovarus (CTEV) is a complex three-dimensional deformity with an incidence of 1–3 per 1000 live births. The
A less invasive surgical treatment of clubfoot is increasingly considered, it aims to limit extensive exposure, to improve the functional and cosmetic outcome and to lower the risk of stiffness and recurrence of the deformity. The
Early results of
Aim: To compare the rate of relapse of
Outcome studies of the
Statement of purpose:. A randomised clinical trial was undertaken to find out if treatment time and failure rate in children treated by the
Introduction. The
Aim. To compare outcomes for children treated for idiopathic clubfeet with the
Introduction: Clubfoot occurs in approximately 1 in 1,000 live births and is one of the most common congenital birth defects. Although there are multiple reports of successful treatment of idiopathic clubfeet with the
The purpose of this study was to describe the clinical course of patients with Down's syndrome (DS) and congentital talipes equinovarus (CTEV) treated with the